MATINAS BIOPHARMA HOLDINGS, INC. Interest Expense, Lessee, Assets under Capital Lease
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Interest Expense, Lessee, Assets under Capital Lease of $13.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseLesseeAssetsUnderCapitalLease · last filed 2019-04-01
- MATINAS BIOPHARMA HOLDINGS, INC. interest expense, lessee, assets under capital lease for the quarter ending 2018-12-31 was $3.60K, a 2.86% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. interest expense, lessee, assets under capital lease for the quarter ending 2018-09-30 was $5.60K, a 99.32% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. interest expense, lessee, assets under capital lease for the quarter ending 2018-06-30 was $1.10K, a 7.87% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. interest expense, lessee, assets under capital lease for the quarter ending 2018-03-31 was $2.70K, a 435.71% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. interest expense, lessee, assets under capital lease for fiscal 2018 was $13.00K, a 116.67% increase from fiscal 2017.
- MATINAS BIOPHARMA HOLDINGS, INC. interest expense, lessee, assets under capital lease for fiscal 2017 was $6.00K, a 400.83% increase from fiscal 2016.
- MATINAS BIOPHARMA HOLDINGS, INC. interest expense, lessee, assets under capital lease for fiscal 2016 was $1.20K, a 35.37% increase from fiscal 2015.
- MATINAS BIOPHARMA HOLDINGS, INC. interest expense, lessee, assets under capital lease for fiscal 2015 was $885.00, a 35.82% decline from fiscal 2014.
| Period end | Interest Expense, Lessee, Assets under Capital Lease 3 month | Interest Expense, Lessee, Assets under Capital Lease 6 month | Interest Expense, Lessee, Assets under Capital Lease 6 month as first filed | Interest Expense, Lessee, Assets under Capital Lease 9 month | Interest Expense, Lessee, Assets under Capital Lease 9 month as first filed | Interest Expense, Lessee, Assets under Capital Lease 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | $3.60K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $9.20K derived: sum of 2 quarters · filed 2019-04-01 | $10.30K derived: sum of 3 quarters · filed 2019-04-01 | $13.00K 10-K · filed 2019-04-01 | ||
| 2018-09-30 | $5.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $6.70K derived: sum of 2 quarters · filed 2018-11-09 | $9.40K 10-Q · filed 2018-11-09 | $12.90K derived: sum of 4 quarters · filed 2019-04-01 | ||
| 2018-06-30 | $1.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $3.80K 10-Q · filed 2018-08-09 | $7.30K derived: sum of 3 quarters · filed 2019-04-01 | $830.30K derived: sum of 4 quarters · filed 2019-04-01 | ||
| 2018-03-31 | $2.70K 10-Q · filed 2018-05-09 | $6.20K derived: sum of 2 quarters · filed 2019-04-01 | $829.20K derived: sum of 3 quarters · filed 2019-04-01 | $830.39K derived: sum of 4 quarters · filed 2019-04-01 | ||
| 2017-12-31 | $3.50K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $826.50K derived: sum of 2 quarters · filed 2019-04-01 | $827.69K derived: sum of 3 quarters · filed 2019-04-01 | $6.00K 10-K · filed 2019-04-01 | ||
| 2017-09-30 | $823.00K 10-Q · filed 2017-11-14 | $824.19K derived: sum of 2 quarters · filed 2017-11-14 | $2.50K 10-Q · filed 2018-11-09 | $2.87M 10-Q · filed 2017-11-14 | $824.54K derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-06-30 | $1.19K 10-Q · filed 2017-08-08 | $504.00 10-Q · filed 2018-08-09 | $1.70K 10-Q · filed 2017-08-08 | $1.54K derived: sum of 3 quarters · filed 2018-05-09 | $2.69K derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-03-31 | $504.00 10-Q · filed 2018-05-09 | $349.00 derived: sum of 2 quarters · filed 2018-05-09 | $1.50K derived: sum of 3 quarters · filed 2018-05-09 | $1.65K derived: sum of 4 quarters · filed 2018-05-09 | ||
| 2016-12-31 | -$155.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $994.00 derived: sum of 2 quarters · filed 2017-03-31 | $1.15K derived: sum of 3 quarters · filed 2017-03-31 | $1.20K 10-K · filed 2017-03-31 | ||
| 2016-09-30 | $1.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.30K derived: sum of 2 quarters · filed 2016-11-14 | $1.35K 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | $154.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $204.00 10-Q · filed 2016-08-15 | ||||
| 2016-03-31 | $50.00 10-Q · filed 2016-05-13 | |||||
| 2015-12-31 | $885.00 10-K · filed 2017-03-31 | |||||
| 2015-03-31 | $325.00 10-Q · filed 2016-05-13 | |||||
| 2014-12-31 | $1.38K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |